#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	722	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1184	32.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	311	313	ACG	33;33;33	A;C;G	33;33;33	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	A888G	SNP	888	888	A	61	61	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	C897G	SNP	897	897	C	70	70	G	24	G	24	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	T898C	SNP	898	898	T	71	71	C	24	C	24	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	G906T	SNP	906	906	G	79	79	T	26	T	26	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	G908A	SNP	908	908	G	81	81	A	28	A	28	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	A918T	SNP	918	918	A	91	91	T	32	T	32	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	A943G	SNP	943	943	A	116	116	G	58	G	58	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	422	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l6.c30.ctg.2	187	29.2	0	.	n	.	0	G991T	SNP	991	991	G	164	164	T	46	T	46	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1350	1352	AGC	42;42;42	A,G;G;C	28,14;42;42	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	1	SNP	p	R234F	1	.	.	700	702	TTC	825	827	TTC	111;110;106	T;T;C	111;109;104	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1125	1127	CGT	114;114;113	C,A;G;T	112,1;113;112	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	0	HET	.	.	.	T180C	.	180	180	T	305	305	T	70	T,C	40,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	0	HET	.	.	.	C255T	.	255	255	C	380	380	C	98	C,T	42,55	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	2522	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1568	83.0	0	HET	.	.	.	T999C	.	999	999	T	1124	1124	T	106	T,C	61,43	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1070	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1737	32.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1542	1544	AAA	7;7;6	A;A;A	7;7;6	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1396	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1699	44.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1199	1201	GAA	60;58;58	G;A;A,C	60;57;57,1	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	296	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	830	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	126	G	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	131	T	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	218	G,A	215,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	214	C	214	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	197	C,G	196,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	158	T	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	152	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	127	C	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	137	A	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	142	A	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	149	A	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	158	T	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	157	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	179	C	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	182	A	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	172	G	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	169	C,T	166,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	175	T	175	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	220	G	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	226	G	226	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	227	T	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	176	T	175	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	168	G	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	134	C	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	122	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	73	C	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	59	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	6	G	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	14	C	14	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	69	T	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	78	G	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	64	T	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	164	C	163	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	583	150.3	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	113	C,T	56,33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	A303G	SNP	303	303	A	5	5	G	58	G	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	G375A	SNP	375	375	G	77	77	A	86	A	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	G383C	SNP	383	383	G	85	85	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	G385C	SNP	385	385	G	87	87	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	C388G	SNP	388	388	C	90	90	G	10	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	C394T	SNP	394	394	C	96	96	T	4	T	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	3390	Pasteurella_multocida_16S	1551	116	93.97	Pasteurella_multocida_16S.l15.c30.ctg.5	116	116.1	0	.	n	.	0	A411T	SNP	411	411	A	113	113	T	1	T	1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	976	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1489	35.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	212	214	CGT	29;29;29	C;G;T	29;29;29	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	976	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1489	35.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1055	1057	GGC	35;35;33	G;G;C	35;34;33	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1424	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2016	37.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	208	210	AGC	17;12;12	A;G;C	16;12;12	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1424	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2016	37.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	610	612	CTA	34;34;34	C;T;A	34;33;33	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1424	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2016	37.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1129	1131	CAA	52;54;54	C;A;A	52;54;54	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1424	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2016	37.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1228	1230	GGT	49;49;48	G;G;T	48;49;48	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1424	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2016	37.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1798	1800	GTT	29;28;27	G;T;T	29;28;27	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	624	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1540	21.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	575	577	GAA	17;16;15	G;A;A	17;16;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	624	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1540	21.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	755	757	ACC	15;15;15	A;C;C	15;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	624	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1540	21.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	875	877	ACT	19;19;20	A;C;T	19;19;20	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	624	PmrE	1167	1167	96.92	PmrE.l6.c4.ctg.1	1540	21.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1265	1267	ATC	17;17;17	A;T;C	16;17;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	854	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1454	31.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	528	56	acrB	3147	159	91.19	acrB.l6.c30.ctg.1	159	8.5	0	.	p	.	0	N146D	NONSYN	436	438	AAC	141	143	GAT	2;2;2	G;A;T	2;2;2	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2764	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3528	42.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	498	500	ATC	40;37;39	A;T;C	40;37;39	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2764	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3528	42.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2211	2213	AAG	24;25;25	A;A;G	23;25;25	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	532	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1073	26.7	1	SNP	p	R45C	0	.	.	133	135	CGC	336	338	CGC	29;26;28	C;G;C	29;26;28	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	448	acrS	663	663	98.79	acrS.l15.c17.ctg.1	902	25.9	0	.	p	.	0	L34F	NONSYN	100	102	CTC	156	158	TTC	27;28;28	T;T;C	27;28;28	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	448	acrS	663	663	98.79	acrS.l15.c17.ctg.1	902	25.9	0	.	p	.	0	E122G	NONSYN	364	366	GAG	420	422	GGG	31;31;30	G;G;G	31;31;30	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	660	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1165	30.3	0	.	p	.	0	V136L	NONSYN	406	408	GTT	611	613	CTT	46;45;47	C;T;T	45;45;47	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2674	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3072	46.7	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2096	2098	GCA	74;75;76	G;C;A	74;74;76	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2674	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3072	46.7	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2357	2359	ACC	59;59;58	A;C;C	57;57;58	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2674	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3072	46.7	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2666	2668	GCC	38;39;36	G;C;C	38;38;36	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	324	326	GCT	7;7;7	G;C;T	7;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	444	446	GAG	9;8;8	G;A;G	9;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	480	482	TGC	5;5;5	T;G;C	5;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	663	665	GTT	25;26;27	G;T;T	25;26;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	813	815	CAC	32;32;32	C;A;C	32;32;32	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1098	1100	ATG	54;54;53	A;T;G	51;54;53	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1320	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2416	29.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2094	2096	CGC	44;44;45	C;G;C	44;44;45	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	514	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1218	22.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	868	870	ACC	10;10;12	A;C;C	10;10;12	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	514	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1218	22.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	880	882	TCG	15;16;16	T;C;G	15;16;16	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	572	baeR	723	723	97.79	baeR.l6.c4.ctg.1	1148	26.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1638	32.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1347	1349	AAA	18;18;18	A;A;A	16;18;18	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1638	32.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1359	1361	GAG	13;13;13	G;A;G	12;12;13	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1638	32.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1365	1367	CAC	14;15;15	C;A;C	13;15;14	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1040	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1638	32.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1419	1421	GAG	20;19;19	G;A;G	20;18;19	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1110	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1763	33.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	666	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1073	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	792	cysB	975	975	99.38	cysB.l15.c30.ctg.1	1413	30.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	880	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1450	31.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	818	820	GTC	49;49;49	G;T;C	49;47;47	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1490	emrB	1539	1539	99.81	emrB.l15.c17.ctg.1	1969	40.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1042	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1702	32.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	848	850	AGC	25;24;22	A;G;C	25;23;22	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	42	emrE_1	333	146	93.15	emrE_1.l15.c30.ctg.1	153	4.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	700	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1476	25.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	741	743	AGG	27;28;29	A;G;G	27;28;29	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	700	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1476	25.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1131	1133	GAC	16;19;19	G;A;C	16;19;19	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	534	emrR	531	531	100.0	emrR.l15.c30.ctg.1	933	30.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1080	emrY	1539	1539	99.81	emrY.l6.c30.ctg.1	2028	28.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	452	evgA	615	615	99.19	evgA.l6.c17.ctg.1	868	26.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	262	264	CTG	28;25;27	C;T;G	28;25;27	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	375	377	ATA	11;11;11	A;T;A	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	387	389	GTA	11;10;11	G;T;A	11;10;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	540	542	ACG	27;28;27	A;C;G	27;28;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	603	605	GAA	16;16;19	G;A;A	16;16;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	642	644	GCT	36;35;35	G;C;T,G	36;34;34,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	660	662	GAT	34;33;33	G;A;T	34;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	747	749	TCA	33;33;32	T;C;A	33;33;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	876	878	CAG	20;20;20	C;A;G	20;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1014	1016	GTT	26;26;26	G;T;T	26;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1170	1172	GAT	7;8;8	G;A;T	7;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1338	1340	AAT	7;7;6	A;A;T	7;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1359	1361	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1560	1562	AAA	18;21;20	A;A;A	18;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2295	2297	CAT	25;25;24	C;A;T	25;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2349	2351	CAT	24;24;24	C;A;T	24;24;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2367	2369	AGA	22;21;21	A;G;A	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2382	2384	AAT	21;21;21	A;A;T	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2529	2531	TCC	14;14;12	T;C;C	14;14;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2694	2696	ATT	23;22;22	A;T;T	23;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2715	2717	GAT	10;9;11	G;A;T	10;9;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2829	2831	GTT	37;37;38	G;T;T	37;37;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2156	evgS	3594	3594	97.55	evgS.l6.c4.ctg.1	4058	28.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3114	3116	CAC	33;33;32	C;A;C	33;33;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	666	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1264	28.3	1	SNP	p	P64A	0	.	.	190	192	CCA	405	407	CCA	37;37;37	C;C;A	37;37;35	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	666	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1264	28.3	1	SNP	p	P64L	0	.	.	190	192	CCA	405	407	CCA	37;37;37	C;C;A	37;37;35	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	666	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1264	28.3	1	SNP	p	P64H	0	.	.	190	192	CCA	405	407	CCA	37;37;37	C;C;A	37;37;35	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	666	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1264	28.3	1	SNP	p	P64R	0	.	.	190	192	CCA	405	407	CCA	37;37;37	C;C;A	37;37;35	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	666	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1264	28.3	1	SNP	p	P64S	0	.	.	190	192	CCA	405	407	CCA	37;37;37	C;C;A	37;37;35	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	488	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1000	26.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	154	gadW	729	347	95.9	gadW.l6.c30.ctg.1	413	16.9	0	.	p	.	0	S234A	NONSYN	700	702	TCG	215	217	GCG	10;11;11	G;C;G	10;11;11	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	496	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	22.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	360	362	TTA	29;29;30	T;T;A	29;29;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	496	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	22.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	438	440	ATT	16;16;17	A;T;T	16;16;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	496	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	22.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	939	941	GGA	16;15;15	G;G;A	16;15;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	496	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1148	22.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	945	947	CCG	13;14;15	C;C;G	13;14;15	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2251	2253	GAA	56;54;53	G;A;A	56;54;53	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	S83L	0	.	.	247	249	TCG	466	468	TCG	60;58;57	T;C,G;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	S83W	0	.	.	247	249	TCG	466	468	TCG	60;58;57	T;C,G;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	S83I	0	.	.	247	249	TCG	466	468	TCG	60;58;57	T;C,G;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	D87V	0	.	.	259	261	GAC	478	480	GAC	48;48;47	G;A;C	45;45;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	D87H	0	.	.	259	261	GAC	478	480	GAC	48;48;47	G;A;C	45;45;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	478	480	GAC	48;48;47	G;A;C	45;45;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	D87G	0	.	.	259	261	GAC	478	480	GAC	48;48;47	G;A;C	45;45;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2772	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3086	48.3	1	SNP	p	D87N	0	.	.	259	261	GAC	478	480	GAC	48;48;47	G;A;C	45;45;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136I	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136L	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136E	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136H	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136G	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136S	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2292	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2825	43.6	1	SNP	p	R136C	0	.	.	406	408	CGC	629	631	CGC	41;41;42	C;G;C	41;41;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	416	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1027	21.8	0	.	p	.	0	A72P	NONSYN	214	216	GCG	431	433	CCG	33;34;33	C;C;G	33;34;32	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	416	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1027	21.8	0	.	p	.	0	T123A	NONSYN	367	369	ACC	584	586	GCC	28;27;27	G;C;C	27;26;27	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	754	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1345	30.1	0	.	p	.	0	P9S	NONSYN	25	27	CCA	198	200	TCA	32;32;30	T;C;A	32;32;30	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	260	marA	384	384	99.74	marA.l15.c4.ctg.1	751	18.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	380	382	AGC	9;9;9	A;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	482	484	CAT	8;8;7	C;A;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	V45E	0	.	.	133	135	GTG	206	208	GTG	17;17;18	G;T;G	17;17;16	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	I49S	0	.	.	145	147	ATC	218	220	ATC	18;18;18	A;T;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	A70T	0	.	.	208	210	GCA	281	283	GCA	18;18;20	G;C;A	18;18;20	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R73S	0	.	.	217	219	CGT	290	292	CGT	18;18;16	C;G;T	18;18;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R73C	0	.	.	217	219	CGT	290	292	CGT	18;18;16	C;G;T	18;18;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R77C	0	.	.	229	231	CGC	302	304	CGC	16;15;15	C;G;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R77L	0	.	.	229	231	CGC	302	304	CGC	16;15;15	C;G;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	L78M	0	.	.	232	234	CTG	305	307	CTG	14;14;14	C;T;G	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R94S	0	.	.	280	282	CGC	353	355	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	R94H	0	.	.	280	282	CGC	353	355	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	164	marR	435	435	97.7	marR.l15.c4.ctg.1	570	12.7	1	SNP	p	V96E	0	.	.	286	288	GTA	359	361	GTA	13;13;13	G;T;A	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	80	82	TTC	5;5;5	T;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	167	169	ATC	11;11;10	A;T;C	11;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	185	187	GCC	4;4;5	G;C;C	4;4;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	188	190	GTG	5;5;5	G;T;G	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	215	217	GAT	8;8;8	G;A;T	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	236	238	ACC	9;9;8	A;C;C	9;9;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	263	265	TTA	11;11;12	T;T;A	11;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	404	406	CAG	36;36;36	C;A;G	36;36;36	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	D128A	NONSYN	382	384	GAC	443	445	GCC	18;17;18	G;C;C	18;17;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	S163A	NONSYN	487	489	TCG	548	550	GCG	21;22;19	G;C;G	21;22;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	A227_L228del	DEL	679	679	G	739	739	G	10	G	8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	L231V	NONSYN	691	693	CTT	746	748	GTT	11;12;12	G;T;T	7;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	594	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1476	21.0	0	.	p	.	0	R285fs	FSHIFT	853	853	C	908	908	C	22	C	22	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	776	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1421	27.9	0	.	p	.	0	V12trunc	TRUNC	34	34	G	64	64	G	33	G	33	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	776	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1421	27.9	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	121	123	CAG	11;13;13	C;A;G	11;13;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	776	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1421	27.9	0	.	p	.	0	T83I	NONSYN	247	249	ACC	271	273	ATC	21;22;21	A;T;C	20;20;21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	776	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1421	27.9	0	.	p	.	0	I99M	NONSYN	295	297	ATA	319	321	ATG	13;15;15	A;T;G	13;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	776	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1421	27.9	0	.	p	.	0	A130T	NONSYN	388	390	GCC	412	414	ACC	12;12;12	A;C;C	12;12;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2048	2050	ACC	58;57;56	A;C;C	57;56;55	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2441	2443	CAA	34;36;37	C,A;A;A	33,1;34;36	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2609	2611	ATT	33;31;31	A;T;T	33;31;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2693	2695	GTT	48;50;51	G;T;T	48;50;51	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2801	2803	GAG	19;19;19	G;A;G	19;19;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3029	3031	ATG	26;25;25	A;T;G	26;25;25	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2854	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3596	42.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3164	3166	GAT	44;42;41	G;A;T	44;41;41	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2638	mdtC	3078	3078	98.67	mdtC.l15.c4.ctg.1	3318	42.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	346	348	ATG	19;21;22	A;T;G	18;21;21	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2638	mdtC	3078	3078	98.67	mdtC.l15.c4.ctg.1	3318	42.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	832	834	ATC	40;40;41	A;T;C	40;40;41	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2638	mdtC	3078	3078	98.67	mdtC.l15.c4.ctg.1	3318	42.2	0	.	p	.	0	L533V	NONSYN	1597	1599	CTG	1807	1809	GTG	55;55;54	G;T;G	55;52;54	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2638	mdtC	3078	3078	98.67	mdtC.l15.c4.ctg.1	3318	42.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3148	3150	CAC	7;7;7	C;A;C	7;7;7	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1120	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	32.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	161	163	GAA	15;15;15	G;A;A	15;15;15	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1120	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	32.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	830	832	GCG	45;45;47	G;C;G	45;45;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1120	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	32.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1172	1174	ATC	47;47;46	A;T;C	46;47;46	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1120	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	32.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1475	1477	TTT	31;32;32	T;T;T	31;32;32	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1318	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1602	44.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2948	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3528	44.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1090	1092	ACC	32;33;35	A;C;C	32;31;35	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2948	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3528	44.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2332	2334	GAC	71;70;69	G;A,G;C	70;67,1;68	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	796	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1499	23.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	637	639	ATC	37;36;37	A;T;C	37;36;37	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	796	mdtG	1227	172	99.42	mdtG.l15.c30.ctg.2	180	20.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	3	5	GGA	2;2;3	G;G;A	2;2;3	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	680	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1374	25.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	404	406	TGT	26;26;26	T;G;T	26;26;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	680	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1374	25.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	974	976	TTG	28;28;27	T,G;T;G	27,1;27;27	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	680	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1374	25.9	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1079	1081	CAG	13;14;13	C;A;G	13;14;13	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	680	mdtH	1209	1209	98.1	mdtH.l15.c30.ctg.1	1374	25.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1184	1186	ACG	9;9;10	A;C;G	9;9;10	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1112	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1622	36.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	763	765	TCC	45;46;45	T;C;C	45;46;45	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	720	mdtN	1032	1032	98.16	mdtN.l15.c4.ctg.1	1505	25.7	0	.	p	.	0	V119I	NONSYN	355	357	GTT	563	565	ATT	23;24;23	A;T;T	23;24;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	183	185	ATG	17;18;19	A;T;G	17;18;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	249	251	ATC	26;28;28	A;T;C	26;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	498	500	CGC	46;46;46	C;G;C	46;46;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	864	866	AGC	44;45;44	A;G;C	44;45;44	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1065	1067	GTG	46;45;45	G;T;G	46;44;45	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1128	1130	AAC	6;6;6	A;A;C	5;6;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1173	1175	GTC	31;31;31	G;T;C	31;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1203	1205	ATA	50;49;48	A;T;A	50;49;48	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1311	1313	TCT	35;33;32	T;C;T	35;32;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1698	1700	GCG	31;29;29	G;C;G	29;29;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1644	mdtO	2052	2052	98.15	mdtO.l6.c17.ctg.1	2381	36.8	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1911	1913	ATC	36;36;37	A;T;C	36;36;37	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	610	612	GCG	46;49;50	G;C;G	45;48;49	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	784	786	ACC	34;34;33	A;C;C	34;33;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	856	858	CGC	32;32;34	C;G;C	32;32;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	973	975	GCT	23;25;23	G;C;T	22;25;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1057	1059	AAA	14;13;14	A;A;A	14;13;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1075	1077	CGA	17;17;17	C;G;A	17;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1240	1242	GCC	35;37;34	G;C;C	35;37;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1252	1254	GAT	36;34;34	G;A;T	36;34;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1018	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1767	30.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1669	1671	GCT	10;9;8	G;C;T	9;9;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2376	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3827	33.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1506	1508	AAG	28;28;27	A;A;G	28;28;27	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2376	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3827	33.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2583	2585	CTG	32;33;33	C;T;G	32;33;33	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	158	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	165	25.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1484	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	2197	36.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1058	1060	AAC	35;35;34	A;A;C	35;34;34	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1484	msbA	1749	1749	98.68	msbA.l6.c17.ctg.1	2197	36.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1604	1606	ATA	50;51;50	A;T;A	50;51;50	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1182	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1666	38.0	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1218	1220	GTG	36;37;35	G;T;G	36;37;35	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1182	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1666	38.0	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1296	1298	GAT	48;47;47	G;A;T	47;47;46	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1182	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1666	38.0	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1299	1301	CTG	47;48;49	C;T;G	46;48;49	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	279	281	TGT	15;15;16	T;G;T	15;15;16	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	549	551	ACC	23;23;23	A;C;C	23;23;23	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	759	761	GAC	18;17;19	G;A;C	18;17;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	1	SNP	p	R15C	0	.	.	43	45	CGC	243	245	CGC	32;30;30	C;G;C	32;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	1	SNP	p	S33R	0	.	.	97	99	AGC	297	299	AGC	16;16;16	A;G;C	16;16;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	1	SNP	p	G131D	0	.	.	391	393	GGC	591	593	GGC	31;31;29	G;G;C	31;30;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	1	SNP	p	R203C	0	.	.	607	609	CGT	807	809	CGT	25;27;27	C;G;T	25;26;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	358	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1106	17.4	1	SNP	p	R203L	0	.	.	607	609	CGT	807	809	CGT	25;27;27	C;G;T	25;26;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1026	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1487	36.9	1	SNP	p	G141E	0	.	.	421	423	GGT	613	615	GGT	49;50;49	G;G;T	49;50;48	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1026	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1487	36.9	1	SNP	p	G141D	0	.	.	421	423	GGT	613	615	GGT	49;50;49	G;G;T	49;50;48	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1026	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1487	36.9	1	SNP	p	R154A	0	.	.	460	462	CGT	652	654	CGT	45;44;42	C;G;T	45;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1026	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1487	36.9	1	SNP	p	R154D	0	.	.	460	462	CGT	652	654	CGT	45;44;42	C;G;T	45;44;42	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2228	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2682	44.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1854	1856	TCG	59;58;58	T;C;G	58;58;57	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2228	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2682	44.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2469	2471	AAC	47;46;46	A;A;C	47;45;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2228	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2682	44.5	1	SNP	p	A85T	0	.	.	253	255	GCG	483	485	GCG	65;66;65	G;C;G	62;63;63	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2228	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2682	44.5	1	SNP	p	D111H	0	.	.	331	333	GAT	561	563	GAT	37;35;36	G;A;T	37;35;36	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2228	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2682	44.5	1	SNP	p	S129P	0	.	.	385	387	TCC	615	617	TCC	44;44;43	T,G;C;C	42,1;43;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1382	parE_1	1893	1893	97.46	parE_1.l15.c4.ctg.1	2177	33.2	0	.	p	.	0	H51D	NONSYN	151	153	CAC	188	190	GAC	10;13;13	G,C;A;C	1,1;7;10	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1382	parE_1	1893	1893	97.46	parE_1.l15.c4.ctg.1	2177	33.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1463	1465	GAT	55;55;52	G;A;T	55;55;52	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1320	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1854	38.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1308	1310	GAT	56;56;53	G,T;A;T	54,1;56;53	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	V146F	0	.	.	436	438	GTT	703	705	GTT	54;53;52	G;T;T	54;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1804	1806	CAG	56;58;56	C;A;G	56;58;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1804	1806	CAG	56;58;56	C;A;G	56;58;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1843	1845	CAC	43;43;42	C;A;C	43;43;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1852	1854	CGT	40;41;41	C;G;T	38;39;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1852	1854	CGT	40;41;41	C;G;T	38;39;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1858	1860	TCC	39;36;37	T;C;C	37;35;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1864	1866	CTC	36;36;33	C;T;C	36;36;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1954	1956	ACC	44;43;43	A;C;C	44;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1957	1959	CCT	43;45;44	C;C;T	43;45;44	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3782	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4527	44.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2326	2328	CGT	67;69;67	C;G;T	67;69;67	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	.	n	.	0	A226G	SNP	226	226	A	345	345	G	334	G	333	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	.	n	.	0	C719T	SNP	719	719	C	838	838	T	258	T,C	167,87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	1	SNP	n	A794G	0	.	.	794	794	A	913	913	A	291	A	285	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	1	SNP	n	A794T	0	.	.	794	794	A	913	913	A	291	A	285	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	1	SNP	n	G926A	0	.	.	926	926	G	1045	1045	G	278	G	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	1	SNP	n	G926T	0	.	.	926	926	G	1045	1045	G	278	G	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	1	SNP	n	G926C	0	.	.	926	926	G	1045	1045	G	278	G	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	A79G	.	79	79	A	198	198	A	252	A,G	179,66	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	T273A	.	273	273	T	392	392	T	283	T,A	189,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	C183T	.	183	183	C	302	302	C	275	C,T	225,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	T90C	.	90	90	T	209	209	T	259	T,C	189,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	A250T	.	250	250	A	369	369	A	309	A,T	232,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	1000	99.8	rrsB+.l15.c30.ctg.1	1119	270.1	0	HET	.	.	.	A253T	.	253	253	A	372	372	A	313	A,T	236,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	515	342.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	248	A	244	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	515	342.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	248	A	244	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	515	342.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	248	A	244	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	140	100.0	rrsB+.l15.c30.ctg.5	140	70.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	50	50	A	86	A	86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	54	54	C	90	C,G	89,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	58	58	C	96	C	96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	66	66	G	95	G	95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	.1023G	INS	1023	1023	T	71	71	G	94	G	94	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	9832	rrsB+	1542	136	94.89	rrsB+.l15.c30.ctg.6	136	46.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	86	86	T	70	T	69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c30.ctg.1	867	27.7	1	SNP	p	R20H	0	.	.	58	60	CGC	245	247	CGC	39;38;38	C;G;C	39;37;38	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c30.ctg.1	867	27.7	1	SNP	p	G121D	0	.	.	361	363	GGT	548	550	GGT	50;50;51	G;G;T	50;50;51	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	316	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	811	20.8	1	SNP	p	A12S	0	.	.	34	36	GCA	263	265	GCA	32;33;34	G;C;A	32;33;34	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	376	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1197	16.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	674	tet-	1206	1206	99.92	tet-.l15.c30.ctg.1	1656	21.7	0	.	p	.	0	T171A	NONSYN	511	513	ACT	756	758	GCT	23;24;23	G;C;T	23;24;23	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	218	tetC	594	594	99.66	tetC.l15.c4.ctg.1	1003	11.6	0	.	p	.	0	S152D	NONSYN	454	456	AGT	659	661	GAT	9;9;10	G;A;T	9;9;10	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	252	tetD	417	417	100.0	tetD.l15.c4.ctg.1	853	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetD;TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	356	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1037	18.5	1	SNP	p	H64Y	0	.	.	190	192	CAC	386	388	CAC	23;23;23	C;A;C	23;23;23	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	356	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1037	18.5	1	SNP	p	N82H	0	.	.	244	246	AAT	440	442	AAT	16;16;17	A;A;T	16;16;17	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	354	tetR_1	624	624	100.0	tetR_1.l15.c30.ctg.1	1023	18.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1466	tolC	1488	1488	98.66	tolC.l15.c4.ctg.1	1919	41.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
